Drug
Tazobactam clinical trials
- studies test it
- 7
- open now
- 2
- in phase 3
- 2
- first study started
- 1997
Keep track of what changes. Save the Tazobactam studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2010 | 2 |
| 2018 | 1 |
| 2021 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 5
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Murdoch Childrens Research Institute (1) · Institute of Liver and Biliary Sciences, India (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Bassett Healthcare (1)
Often tested with
Tested in the same studies.
Piperacillin (5) · Vancomycin (2) · Ceftolozane (2) · Cefepime (1) · Ceftazidime (1) · Amikacin (1) · Ciprofloxacin (1) · Metronidazole (1)
Studies
Open first, then newest update. How each study uses Tazobactam is read from its arms, and is right about nine times in ten.
Testing it · 7
- The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)RecruitingPhase 4Bassett HealthcareNCT07556107Written as Piperacillin + Tazobactam
- Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver TransplantationNot yet recruitingPhase 3IRCCS Azienda Ospedaliero-Universitaria di BolognaNCT07759453Written as Piperacillin + Tazobactam
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedPhase 4Murdoch Childrens Research InstituteNCT04948463Written as Piperacillin and Tazobactam for Injection
- Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver DonorsCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT03765645Written as Piperacillin + Tazobactam
- Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal InfectionsCompletedPhase 2Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)NCT01147640Written as CXA-101/ tazobactam and metronidazole
- Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy SubjectsCompletedPhase 1Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)NCT02508753Written as CXA-101/tazobactam
- Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT00003805Written as tazobactam sodium
Given in every arm · 1 — Tazobactam is usual care beside what is tested
As the comparator · 3 — what is tested is compared with Tazobactam
- Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South KoreaNot yet recruitingNot applicableCHOSEOK YOONNCT06977347Written as Piperacillin/tazobactam + Levofloxacin
- Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)CompletedPhase 3Merck Sharp & Dohme LLCNCT02493764Written as Tazobactam
- Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure InfectionCompletedPhase 3BayerNCT00402727Written as Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid
Codes
What other systems call Tazobactam · ClinicalTrials.gg INT006818
- MeSH (NLM) D000078142TazobactamConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) SE10G96M8WTAZOBACTAMConfirmed FDA, NLM, Wikidata
- RxNorm 37617Confirmed FDA, Wikidata
- Wikidata Q423376tazobactamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62079TazobactamOne source FDA
- DrugBank DB01606One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078142 | Tazobactam | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | SE10G96M8W | TAZOBACTAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 37617 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423376 | tazobactam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62079 | Tazobactam | One source FDA |
| DrugBank | DB01606 | — | One source Wikidata |
Also registered as tazobactam sodium (UNII UXA545ABTT · RxNorm 221167).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.